Business Description
Krka DD
ISIN : SI0031102120
Description
Krka DD engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resorts, and tourist services. The company products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, and Oncology; Non-prescription products include Cold and cough products, nasal products, vitamins and minerals, and hair care products; and Animal health products include Antimicrobials and disinfectants, among others. It operates across the European Union, South-East Europe, East Europe region, and Others. The company derives a majority of its revenue from the European Union.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 44.75 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.03 | |||||
| Interest Coverage | 669.65 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 6.95 | |||||
| Beneish M-Score | -2.39 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.1 | |||||
| 3-Year EBITDA Growth Rate | 2 | |||||
| 3-Year EPS without NRI Growth Rate | 2.9 | |||||
| 3-Year FCF Growth Rate | -31.7 | |||||
| 3-Year Book Growth Rate | 7.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 6.57 | |||||
| Future 3-5Y Total Revenue Growth Rate | 5.19 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.45 | |||||
| 9-Day RSI | 52.04 | |||||
| 14-Day RSI | 52.1 | |||||
| 6-1 Month Momentum % | 3.75 | |||||
| 12-1 Month Momentum % | 27.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.82 | |||||
| Quick Ratio | 2.55 | |||||
| Cash Ratio | 1.21 | |||||
| Days Inventory | 258.07 | |||||
| Days Sales Outstanding | 102.25 | |||||
| Days Payable | 68.75 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 5.43 | |||||
| Dividend Payout Ratio | 0.66 | |||||
| 3-Year Dividend Growth Rate | 15.8 | |||||
| Forward Dividend Yield % | 5.43 | |||||
| 5-Year Yield-on-Cost % | 12.74 | |||||
| 3-Year Average Share Buyback Ratio | 0.4 | |||||
| Shareholder Yield % | 5.91 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 56.55 | |||||
| Operating Margin % | 21.39 | |||||
| Net Margin % | 18.93 | |||||
| FCF Margin % | 10.57 | |||||
| ROE % | 16.23 | |||||
| ROA % | 12.76 | |||||
| ROIC % | 17.68 | |||||
| ROC (Joel Greenblatt) % | 27.79 | |||||
| ROCE % | 17.57 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 11.83 | |||||
| Forward PE Ratio | 12.18 | |||||
| PE Ratio without NRI | 12.21 | |||||
| Shiller PE Ratio | 15.36 | |||||
| Price-to-Owner-Earnings | 14.46 | |||||
| PEG Ratio | 1.25 | |||||
| PS Ratio | 2.24 | |||||
| PB Ratio | 1.94 | |||||
| Price-to-Tangible-Book | 2.03 | |||||
| Price-to-Free-Cash-Flow | 21.14 | |||||
| Price-to-Operating-Cash-Flow | 12.34 | |||||
| EV-to-EBIT | 8.81 | |||||
| EV-to-EBITDA | 7.17 | |||||
| EV-to-Revenue | 1.94 | |||||
| EV-to-FCF | 18.35 | |||||
| Price-to-Projected-FCF | 0.9 | |||||
| Price-to-DCF (Earnings Based) | 0.65 | |||||
| Price-to-DCF (FCF Based) | 1.69 | |||||
| Price-to-Median-PS-Value | 1.32 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.07 | |||||
| Price-to-Graham-Number | 1.05 | |||||
| Price-to-Net-Current-Asset-Value | 3.63 | |||||
| Earnings Yield (Greenblatt) % | 11.35 | |||||
| FCF Yield % | 4.73 | |||||
| Forward Rate of Return (Yacktman) % | 12.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Krka DD Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,900.517 | ||
| EPS (TTM) (€) | 11.67 | ||
| Beta | 0 | ||
| Volatility % | 11.36 | ||
| 14-Day RSI | 52.1 | ||
| 14-Day ATR (€) | 1.749484 | ||
| 20-Day SMA (€) | 137.775 | ||
| 12-1 Month Momentum % | 27.06 | ||
| 52-Week Range (€) | 109 - 150 | ||
| Shares Outstanding (Mil) | 30.75 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Krka DD Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Krka DD Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Krka DD Frequently Asked Questions
What is Krka DD(XLJU:KRKG)'s stock price today?
The current price of XLJU:KRKG is €138.00. The 52 week high of XLJU:KRKG is €150.00 and 52 week low is €109.00.
When is next earnings date of Krka DD(XLJU:KRKG)?
The next earnings date of Krka DD(XLJU:KRKG) is .
Does Krka DD(XLJU:KRKG) pay dividends? If so, how much?
The Dividend Yield %  of Krka DD(XLJU:KRKG) is 5.43% (As of Today), Highest Dividend Payout Ratio of Krka DD(XLJU:KRKG) was 0.79. The lowest was 0.4. And the median was 0.54. The  Forward Dividend Yield % of Krka DD(XLJU:KRKG) is 5.43%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers